Ofir Guy

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return13%(22%)(10%)(31%)0%
Purchase Success Rate3 of 30 of 31 of 30 of 30 of 3
Average Sale Return----------
Sale Success Rate----------

Raphael Pharmaceutical Inc.

Other » Other

Chief Financial Officer, Director:

Holdings: 1.27M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--